Clinical trials
Completed Myelodysplastic Syndromes trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 3 |
| 2010 | 3 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 34 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 5 |
| Children's Oncology Group | 5 |
| Novartis Pharmaceuticals | 4 |
| AbbVie | 2 |
| Institut de Recherches Internationales Servier | 2 |
| Celgene Corporation | 1 |
| Cleave Therapeutics, Inc. | 1 |
| Forma Therapeutics, Inc. | 1 |
| GCP-Service International West GmbH | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 34 |
| Leukemia, Myeloid, Acute | 16 |
| Leukemia | 7 |
| Leukemia, Myelomonocytic, Chronic | 7 |
| Anemia, Refractory, with Excess of Blasts | 5 |
| Anemia, Refractory | 3 |
| Lymphoma | 3 |
| Myeloproliferative Disorders | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Anemia | 2 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.